Grantee & Partner News | National Center for Advancing Translational Sciences

Skip to main content

U.S. Department of Health & Human Services

National Institutes of Health

In the Spotlight

Boy asleep at a desk with his head on a book

Children’s Sleep Linked to Brain Development

NIH Research Matters ∙ 08/30/2022 ∙ CTSA Program

Scientists have long recognized that getting enough sleep during childhood can benefit developing brains. However, the underlying brain mechanisms are not well understood. And although experts say that children ages 6 to 12 should get at least nine hours of sleep each day, it’s been unclear how less sleep might affect a child’s brain.

To get some answers, a research team led by Dr. Ze Wang of the University of Maryland and supported by NCATS’ CTSA Program set out to see how lack of sleep affects brain structure and other outcomes. Learn more about their research in The Lancet Child & Adolescent Health.

September 2022

How Long Older Adults Will Live Comes Down to 17 Often Surprising Factors
Duke University Health System ∙ 09/28/2022 ∙ CTSA Program
Study: Often Overlooked, Molecules Called Glycans Regulate COVID-19 Spike Protein Function
University at Buffalo ∙ 09/26/2022 ∙ CTSA Program
Life Expectancy Tool May Improve Quality of Life for Patients with Dementia
University of California, San Francisco ∙ 09/26/2022 ∙ CTSA Program
UAMS Researchers Find Changes in Monkeypox Genome That May Explain Its Recent Rapid Spread
University of Arkansas for Medical Sciences ∙ 09/26/2022 ∙ CTSA Program
Detecting the Earliest Population Changes of COVID-19 Activity with Wearable Devices
The Scripps Research Institute ∙ 09/23/2022 ∙ CTSA Program
A Consistent Lack of Sleep Negatively Impacts Immune Stem Cells
GhScientific ∙ 09/23/2022 ∙ CTSA Program
Landmark Study of Biomarker Data May Enable Better Treatment for Early Onset Dementia
University of California, San Francisco ∙ 09/22/2022 ∙ NCATS
Accurate Assessment of Heart Rhythm Can Optimize Chemotherapy Use
UNC Lineberger Comprehensive Cancer Center ∙ 09/22/2022 ∙ CTSA Program
University of Kansas Medical Center Announces Nearly $27 Million NIH Grant to Accelerate Clinical and Translational Research in the Region
University of Kansas Medical Center ∙ 09/21/2022 ∙ CTSA Program
A Consistent Lack of Sleep Negatively Impacts Immune Stem Cells, Increasing Risk of Inflammatory Disorders and Heart Disease
Icahn School of Medicine at Mount Sinai ∙ 09/21/2022 ∙ NCATS
Spirituality, Religion Linked to Heart Health Among Black Americans
NIH Research Matters ∙ 09/20/2022 ∙ CTSA Program
Can Children Swab Themselves for COVID-19? New Study Suggests Yes
Georgia Institute of Technology ∙ 09/20/2022 ∙ CTSA Program
UAMS Part of $6 Million National Effort to Make Testing for Toxins in Water and People Less Costly, Easier
University of Arkansas for Medical Sciences ∙ 09/20/2022 ∙ CTSA Program
UAMS Researcher Receives Prestigious National Award, $1 Million to Support Falls Research in Older Adults
University of Arkansas for Medical Sciences ∙ 09/19/2022 ∙ CTSA Program
Monthly Caps on Out-of-Pocket Costs Could Provide Financial Relief to Privately Insured Patients
Boston University School of Public Health ∙ 09/16/2022 ∙ NCATS
Office of New Drugs Regulatory Science Research
U.S. Food and Drug Administration, Center for Drug Evaluation and Research ∙ 09/13/2022 ∙ NCATS
Study Describes How Best Practices Can be Applied to Community Engagement Programs
Boston University School of Medicine ∙ 09/12/2022 ∙ CTSA Program
Biomedical Advance Targets a Major Contributor to Cardiovascular Disease
Florida International University, College of Engineering & Computing ∙ 09/12/2022 ∙ Division of Preclinical Innovation
New Study Describes How Best Practices Can Be Applied to Community Engagement Programs
Boston University School of Medicine ∙ 09/12/2022 ∙ CTSA Program
$61M Grant Funds Translational Science at Weill Cornell Medicine
Weill Cornell Medicine ∙ 09/09/2022 ∙ CTSA Program
Researchers Identify a Potential Path Against Inherited Neurological Disease
Icahn School of Medicine at Mount Sinai ∙ 09/08/2022 ∙ NCATS
Tackling Inflammatory Bowel Disease with Tumbling Microrobots
Purdue University ∙ 09/05/2022 ∙ NCATS
Cedars-Sinai Study Highlights Cancer Disparities in LA County
Cedars Sinai ∙ 09/05/2022 ∙ CTSA Program
Using Improv to Address COVID Vaccine Hesitancy
University of Rochester Medical Center ∙ 09/01/2022 ∙ CTSA Program
Answering the Challenges of Rare Disease Market Access with HEOR
AmerisourceBergen Corporation ∙ 09/01/2022 ∙ GARD

August 2022

Children’s Sleep Linked to Brain Development
NIH Research Matters ∙ 08/30/2022 ∙ CTSA Program
Leading Translational Gastroenterology Research
Northwestern University, Feinberg School of Medicine ∙ 08/30/2022 ∙ Rare Diseases
Full-Dose Anticoagulation Treatment Prevented Blood Clots in COVID-19 Patients
Brigham and Women's Hospital ∙ 08/29/2022 ∙ CTSA Program
NIH-Funded Pediatric COVID-19 Testing Study Finds School-Aged Children Can Self-Swab
NIBIB ∙ 08/26/2022 ∙ CTSA Program
National Institutes of Health Renews Mayo Clinic’s $48 Million Clinical and Translational Science Award
Mayo Clinic ∙ 08/25/2022 ∙ CTSA Program
Religious Practices, Spirituality Associated with Higher Levels of Heart Health Among African Americans
Mayo Clinic ∙ 08/24/2022 ∙ CTSA Program
How New Motion-Sensing Technology May Help Standardize Back-Pain Care
The Ohio State University ∙ 08/23/2022 ∙ CTSA Program
Opiant Pharmaceuticals Announces Notice of Allowance for U.S. Patent with Claims Covering OPNT004 for the Treatment of Cannabinoid Hyperemesis Syndrome
Opiant ∙ 08/22/2022 ∙ NCATS
Diabetes Drug Metformin Shows Potential Benefit in Large COVID-19 Trial
Northwestern University ∙ 08/19/2022 ∙ CTSA Program
Neuron Membrane Lipid May Contribute to Alzheimer’s Development, Progression
Penn State College of Medicine ∙ 08/18/2022 ∙ CTSA Program
COVID OUT Clinical Trial Suggests Metformin Effective at Reducing Odds of Serious Outcomes for COVID-19 Patients Seeking Early Treatment
University of Minnesota Medical School ∙ 08/17/2022 ∙ CTSA Program
New Explorer’s Career Plan? Advocate for Those Fighting Rare Diseases
La Salle University ∙ 08/16/2022 ∙ GARD
Gene Mutations from Patients with Debilitating Seizure and Movement Disorder Created in Mice
University of Maryland School of Medicine ∙ 08/15/2022 ∙ CTSA Program
E-Cigarette Use to Reduce Cigarette Smoking May Not Increase Nicotine Dependence
Penn State ∙ 08/15/2022 ∙ CTSA Program
Scripps Research Scientists Identify How SARS-CoV-2 Spreads in the Middle East
The Scripps Research Institute ∙ 08/15/2022 ∙ CTSA Program
Markey Study: Betamethasone Could Improve Outcomes for Prostate Cancer Radiation Therapy
University of Kentucky ∙ 08/12/2022 ∙ CTSA Program
The Last of the “Unplucked” Gems: Targeting Nav1.7 for Chronic Pain
International Association for the Study of Pain Research Forum ∙ 08/12/2022 ∙ NCATS
CTSC Releases New Team Science Strategy Modules
Case Western Reserve University ∙ 08/12/2022 ∙ CTSA Program
Social Determinants of Health Are Important Contributors to Mortality Disparities in U.S., Study Finds
Johns Hopkins Medicine ∙ 08/11/2022 ∙ CTSA Program
UAMS Researcher Co-Authors Nature Communications Article Showing Higher Heart Failure Rates in Some COVID-19 Patients
University of Arkansas for Medical Sciences ∙ 08/11/2022 ∙ CTSA Program
Monoclonal Antibody Reduces Asthma Attacks in Urban Youth
NIAID ∙ 08/10/2022 ∙ CTSA Program
Study Shows PPE Was Highly Effective Against COVID-19 in Emergency Department Workers
The University of Alabama at Birmingham ∙ 08/08/2022 ∙ CTSA Program
The Digital Phenotype of Vaccination
NattyTech LLC ∙ 08/04/2022 ∙ CTSA Program
Genetic Variant for Alzheimer's Disease May Increase Risk of Chronic Traumatic Encephalopathy After Repetitive Head Impact
Neurology Today (American Academy of Neurology) ∙ 08/04/2022 ∙ CTSA Program
Dance with Me? Study Uses Music to Soothe Dementia Patients and Caregivers
Penn State ∙ 08/02/2022 ∙ CTSA Program

July 2022

Research Brief: Researchers Determine That AI-Based Tools Have Not Yet Reached Full Diagnostic Potential in COVID-19
University of Minnesota Medical School ∙ 07/28/2022 ∙ CTSA Program
Coming Wave of Opioid Overdoses 'Will Be Worse than Ever Been Before'
Northwestern University ∙ 07/28/2022 ∙ CTSA Program
Hearing Loss and Tinnitus Are Common In Cancer Survivors
University of California, San Francisco ∙ 07/27/2022 ∙ CTSA Program
Tracking SARS-CoV-2 Variants in Wastewater
NIH Research Matters ∙ 07/26/2022 ∙ CTSA Program
Study Supports Potential of Genome-to-Treatment (GTRx™) to Guide Physicians in the Management of 500 Treatable Genetic Diseases
Rady Children’s Institute for Genomic Medicine ∙ 07/26/2022 ∙ Division of Preclinical Innovation, GARD
‘Smart Necklace’ Biosensor May Track Health Status Through Sweat
The Ohio State University ∙ 07/22/2022 ∙ CTSA Program
Cultivating an Effective Research Team Through Application of Team Science Principles
Society of Clinical Research Associates ∙ 07/21/2022 ∙ CTSA Program
Do Benefits of Physical, Mental Activity on Thinking Differ for Men and Women?
American Academy of Neurology ∙ 07/20/2022 ∙ NCATS
ACTIV-6 Trials Show No Benefit to Fluticasone Furoate for COVID-19 Symptoms
Duke Clinical Research Institute ∙ 07/19/2022 ∙ CTSA Program
Mobile App for Improving Heart Health Among African Americans Shows Promise, Mayo Study Finds
Mayo Clinic ∙ 07/18/2022 ∙ CTSA Program
Mobile App for Improving Heart Health Among African Americans Shows Promise, Mayo Study Finds
Mayo Clinic ∙ 07/18/2022 ∙ CTSA Program
Immune Modulator Drugs Improved Survival for People Hospitalized with COVID-19
University of North Carolina, Gillings School of Global Public Health ∙ 07/15/2022 ∙ CTSA Program
Funding, Freedom, Flexibility: Graduate Research Fellowship Helps Students Pursue Passions
Arizona State University ∙ 07/15/2022 ∙ 3-D Modeling
UCLA CTSI Receives $59-Million Clinical and Translational Science Award
UCLA Clinical and Translational Science Institute ∙ 07/14/2022 ∙ CTSA Program
Is a National Healthcare Database in our Future?
Smith Hanley Associates, LLC ∙ 07/14/2022 ∙ CTSA Program
NUCATS Town Hall Offers Overview of Resources, 2023 Renewal Efforts
Northwestern University Clinical and Translational Sciences Institute ∙ 07/14/2022 ∙ CTSA Program
Long Day Wear Experience with Water Surface Daily Disposable Contact Lenses
The Ohio State University, College of Optometry ∙ 07/14/2022 ∙ CTSA Program
Study Finds No Benefit to Taking Fluticasone Furoate for COVID-19 Symptoms
Duke University Health System ∙ 07/13/2022 ∙ CTSA Program
Preterm Birth More Likely with Exposure to Phthalates
NIEHS ∙ 07/11/2022 ∙ CTSA Program
NIH-Funded Tissue Chip Investigations to Fly on SpaceX CRS-25 Mission to the ISS
ISS National Laboratory ∙ 07/08/2022 ∙ Tissue Chip
Scientists Develop Tools for Early Detection of SARS-CoV-2 Variants in Wastewater
The Scripps Research Institute ∙ 07/07/2022 ∙ CTSA Program
Taking on a Rare Childhood Disease and Triple-Negative Breast Cancer
Oregon Health & Science University ∙ 07/07/2022 ∙ CTSA Program
The Biomedical Data Translator Consortium Provides Progress Updates in Latest Companion Publications
RENCI ∙ 07/07/2022 ∙ Biomedical Data Translator
Eight Junior Faculty Begin Mentored Career Development KL2 Program
Penn State ∙ 07/07/2022 ∙ CTSA Program
Convalescent Plasma Doesn’t Help Severely Ill COVID Patients: Study
Vanderbilt University Medical Center ∙ 07/07/2022 ∙ CTSA Program
A Major Step Forward for Organ Biofabrication
Harvard John A. Paulson School of Engineering and Applied Sciences ∙ 07/07/2022 ∙ Tissue Chip
International Space Station National Lab Sponsoring Diverse Set of Experiments Launching on SpaceX CRS-25
ISS National Laboratory ∙ 07/06/2022 ∙ Tissue Chip
Study Shows Convalescent Plasma Doesn’t Benefit Severely Ill Patients Hospitalized with COVID-19
Vanderbilt University Medical Center ∙ 07/05/2022 ∙ CTSA Program

June 2022

UCLA Receives Clinical and Translational Science Award from the National Center for Advancing Translational Sciences
University of California, Los Angeles ∙ 06/29/2022 ∙ CTSA Program
Yogic Breathing Affects Cerebrospinal Fluid Dynamics During Breathing Practice
NCCIH ∙ 06/28/2022 ∙ CTSA Program
Grant Money Available to Reduce Health Disparities
University of Virginia ∙ 06/27/2022 ∙ CTSA Program
Local Stroke Center May Be Off Limits to Patients in Black Neighborhoods
University of California, San Francisco ∙ 06/27/2022 ∙ CTSA Program
Genetic Variant May Increase Risk for CTE Severity Among Older Individuals with Repetitive Head Impacts
Boston University School of Medicine ∙ 06/27/2022 ∙ CTSA Program
New Genetic Associations in Pediatric NAFLD Affect Both Risk and Severity
University of California, San Diego ∙ 06/27/2022 ∙ CTSA Program
Light During Sleep in Older Adults Linked to Obesity, Diabetes, High Blood Pressure
Northwestern University ∙ 06/27/2022 ∙ CTSA Program
New Concept Poised to Accelerate Drug Discovery Through Data Mining
RENCI (Renaissance Computing Institute) ∙ 06/24/2022 ∙ Biomedical Data Translator
Changing the Trajectory to Accelerate Rare Disease Drug Development
Certara ∙ 06/24/2022 ∙ Rare Diseases
Modeling a Devastating Childhood Disease on a Chip
Wyss Institute ∙ 06/23/2022 ∙ Tissue Chip
Five-Year, Multi-Site Trial to Assess Lymphedema Prevention Concludes
Vanderbilt University Medical Center ∙ 06/20/2022 ∙ CTSA Program
Walking Gives the Brain a ‘Step-Up’ in Function for Some
University of Rochester Medical Center ∙ 06/17/2022 ∙ CTSA Program
Computer Tool Can Track Stroke Rehabilitation to Boost Recovery
NYU Langone Health ∙ 06/16/2022 ∙ CTSA Program
Treating Parkinson’s Disease with Pinpoint Precision
I Am Intramural Blog ∙ 06/15/2022 ∙ Division of Preclinical Innovation
Pediatric Liver Disease Increases Risk of Developing Type 2 Diabetes
University of California, San Diego ∙ 06/13/2022 ∙ CTSA Program
Study Finds No Benefit to Taking Ivermectin for COVID-19 Symptoms
Duke University Health System ∙ 06/13/2022 ∙ CTSA Program
Santhera and ReveraGen to Present New Data with Vamorolone at 2022 Parent Project Muscular Dystrophy Conference
Santhera Pharmaceuticals ∙ 06/09/2022 ∙ NCATS
Study Reveals Genetic Differences Among Fetal Monocytes
Northwestern University, Feinberg School of Medicine ∙ 06/09/2022 ∙ CTSA Program
How Might Chimeric, Droplet-Forming Proteins Contribute to Cancer?
University at Buffalo ∙ 06/08/2022 ∙ IDG
Using AI to Advance Understanding of Long COVID Syndrome
NIH Director's Blog ∙ 06/07/2022 ∙ CTSA Program
UAMS, CAVHS Studying Health Effects of Arkansas Veterans’ Exposure to Burn Pits in Middle East
University of Arkansas for Medical Sciences ∙ 06/07/2022 ∙ CTSA Program
Causes of Liver Cancer are Changing Around the World: Some Up, Some Down
University of California, San Diego ∙ 06/06/2022 ∙ CTSA Program
NIH-Supported Study Links Poor Sleep to Increased Risk of COPD Flare-ups
NHLBI ∙ 06/06/2022 ∙ CTSA Program
‘You Need a Village’: Clinical Trial Leaders Discuss Collaborations, COVID, and Widening the Lens
The University of Chicago, Polsky Center for Entrepreneurship and Innovation ∙ 06/05/2022 ∙ NCATS
Leveraging Turncoat Immune Cells to Combat Cancer
I Am Intramural Blog ∙ 06/03/2022 ∙ Division of Preclinical Innovation
Exercise Amplifies Immune Attack on Pancreatic Cancer
NYU Langone Health ∙ 06/02/2022 ∙ CTSA Program
RENCI and RTI International Expand Strategic Partnership
RENCI (Renaissance Computing Institute) ∙ 06/02/2022 ∙ Biomedical Data Translator
xCures joins C-Path’s Cure Drug Repurposing Collaboratory to Deliver AI-enabled Data Abstraction of Health Records
xCures ∙ 06/02/2022 ∙ NCATS
Gene Therapy for Rare Eye Disease Safe but Lacks Efficacy in Early Trial
NIH ∙ 06/01/2022 ∙ GARD
Exploiting a Vulnerability in an Aggressive Leukemia Affecting Babies
Boston Children's Hospital ∙ 06/01/2022 ∙ CTSA Program
Consortium Spotlight: Advancing Discoveries in Mitochondrial Diseases
Rare Diseases Clinical Research Network ∙ 06/01/2022 ∙ RDCRN

May 2022

UK Study: Asymptomatic COVID-19 Could Still Cause Pregnancy Risks
University of Kentucky ∙ 05/31/2022 ∙ CTSA Program
UK Study: Asymptomatic COVID-19 Could Still Cause Pregnancy Risks
University of Kentucky ∙ 05/30/2022 ∙ CTSA Program
Inappropriate Antibiotics for Nonhospitalized Kids Cost US At Least $74 Million
Washington University in St. Louis ∙ 05/26/2022 ∙ CTSA Program
Inappropriate Antibiotics for Nonhospitalized Kids Cost US at Least $74 Million
Washington University in St. Louis ∙ 05/26/2022 ∙ CTSA Program
Georgia State Researchers Awarded More Than $6 Million to Fight Emerging Diseases with Midwest Antiviral Drug Discovery Center
Georgia State University ∙ 05/26/2022 ∙ NCATS
Patient Spotlight: Estopinan Family Advocates for TK2-Related Mitochondrial DNA Depletion Syndrome
Rare Diseases Clinical Research Network ∙ 05/26/2022 ∙ RDCRN
U of M Receives NIAID Grant to Develop Drug Treatments for Future Viral Pandemics
University of Minnesota Medical School ∙ 05/23/2022 ∙ Division of Preclinical Innovation
Use Cases Show Translator's Potential to Expedite Clinical Research
North Carolina Translational and Clinical Sciences Institute ∙ 05/23/2022 ∙ Biomedical Data Translator
First Treatment for Eosinophilic Esophagitis Wins FDA Approval
Cincinnati Children's Hospital Medical Center ∙ 05/20/2022 ∙ RDCRN
Deadly Disparities in the Time of COVID-19: Behind the Report
University of Illinois Chicago, Center for Clinical and Translational Science ∙ 05/19/2022 ∙ CTSA Program
Early Stage Investigator Spotlight: Zarazuela Zolkipli-Cunningham Designs Novel Outcome Measures for Mitochondrial Disease
Rare Diseases Clinical Research Network ∙ 05/19/2022 ∙ RDCRN
COVID Booster Needed for Broad Protection against Omicron Variants
The Ohio State University ∙ 05/18/2022 ∙ CTSA Program
A Computational Approach to Curbing Chemotherapy’s Side Effects
I Am Intramural Blog ∙ 05/17/2022 ∙ Division of Preclinical Innovation
Scientists Use Machine Learning Models to Help Identify Long COVID Patients
University of North Carolina School of Medicine ∙ 05/16/2022 ∙ CTSA Program
Innovation through Academic-Industry Partnerships in Clinical Trials
The University of Chicago, Polsky Center for Entrepreneurship and Innovation ∙ 05/16/2022 ∙ NCATS
U.S. Patent Awarded to FIU Researchers Could Be Key to Treating and Preventing Cardiovascular Disease
Florida International University, College of Engineering & Computing ∙ 05/16/2022 ∙ Division of Preclinical Innovation
Healing Chronic Pain? An Update on the NIH’s $2 Billion HEAL Project to End Chronic Pain
Health Rising ∙ 05/15/2022 ∙ HEAL
In New Age of Telemedicine, CHOP Researchers Identify Child Neurology Patients Who Still Require In-Person Visits
The Children’s Hospital of Philadelphia ∙ 05/13/2022 ∙ CTSA Program
Markey Study Finds 'Super Gene' Shows Promise for Preventing Obesity
University of Kentucky ∙ 05/13/2022 ∙ CTSA Program
Clinical and Translational Research Receives $61 Million Grant Support
Washington University in St. Louis ∙ 05/12/2022 ∙ CTSA Program
Five Questions with Qi Sun
Harvard Catalyst ∙ 05/12/2022 ∙ CTSA Program
Sound Pharmaceuticals Receives NIH Grant for Covid-19 Therapy Development
Pharmaceutical Technology ∙ 05/12/2022 ∙ NCATS
U.S. Patent Awarded to FIU Researchers Could Be Key to Treating and Preventing Cardiovascular Disease
Florida International University ∙ 05/11/2022 ∙ Division of Preclinical Innovation
Sound Pharmaceuticals’ NIH Grant for a Novel Oral COVID-19 Treatment Increases to $4.2M
Sound Pharmaceuticals, Inc. ∙ 05/11/2022 ∙ NCATS
Smoking-Cessation Program That Targets Cancer Patients Effective
Washington University School of Medicine in St. Louis ∙ 05/11/2022 ∙ CTSA Program
FSU Continues to Advance Translational Research with New Grant from the National Library of Medicine
Florida State University ∙ 05/11/2022 ∙ CTSA Program
Smell and Taste Loss Less Likely with Newer COVID-19 Variants
Virginia Commonwealth University ∙ 05/11/2022 ∙ CTSA Program
Netflix’s ‘Bandersnatch’ Inspires UAMS Researchers’ Opioid Misuse Game for Adolescents
University of Arkansas for Medical Sciences ∙ 05/11/2022 ∙ CTSA Program
DoD Vision, Focused Translational Team Science Award
Global Database Ltd. ∙ 05/10/2022 ∙ Division of Preclinical Innovation
Medication That Lowers Risk of Overdose Underused
Washington University School of Medicine in St. Louis ∙ 05/10/2022 ∙ CTSA Program
The Essentials of Single IRB Review
Harv ∙ 05/06/2022 ∙ CTSA Program
SC CTSI and Georgia CTSA Partner Creating Innovative Career Training and Advancement Platform
Southern California Clinical and Translational Science Institute ∙ 05/05/2022 ∙ CTSA Program
NCATS-Funded WUSTL Research Uses Synthetic Data to Accurately Model COVID-19 Populations
Federal Laboratory Consortium for Technology Transfer ∙ 05/05/2022 ∙ CTSA Program
Antibiotics Less Effective in Kids with More Appendicitis Pain
FitnessBblogger ∙ 05/05/2022 ∙ CTSA Program
Vitamins, Minerals Improve Symptoms for Children with ADHD
Oregon Health & Science University ∙ 05/04/2022 ∙ CTSA Program
International Study Finds Nearly 13% of COVID-19 Hospitalized Patients Had Serious Neurologic Symptoms
Boston University School of Medicine ∙ 05/04/2022 ∙ CTSA Program
Use Cases Show Translator’s Potential to Expedite Clinical Research
RENCI (Renaissance Computing Institute) ∙ 05/04/2022 ∙ Biomedical Data Translator
BioSystics, Inc. Is Introducing the BioSystics Analytics Platform™️ (BioSystics-AP™️) at the Microphysiology Systems World Summit in New Orleans, May 30–June 3, 2022
BioSystics, Inc. ∙ 05/04/2022 ∙ Tissue Chip
Blood Marker Shows Potential for Tracking Frontotemporal Dementia
NIH Research Matters ∙ 05/03/2022 ∙ Rare Diseases
NJ ACTS Pilot Program Letter of Intent Deadline May 6, 2022
Rutgers Institute for Translational Medicine and Science ∙ 05/02/2022 ∙ CTSA Program
Youths of Color Use Photographs to Highlight Health-care Inequities throughout COVID-19 Pandemic
Boston University School of Medicine ∙ 05/02/2022 ∙ CTSA Program

April 2022

Ridner Concludes Five-Year Multisite Trial to Assess Lymphedema Prevention
Vanderbilt University ∙ 04/28/2022 ∙ CTSA Program
Three CTSA Program Hubs Announced as Recipients of the 2022 AAMC Innovations Award
University of Rochester Center for Leading Innovation and Collaboration (CLIC) ∙ 04/27/2022 ∙ CTSA Program
Synthetic Data Mimics Real Patient Data, Accurately Models COVID-19 Pandemic
Washington University School of Medicine in St. Louis ∙ 04/27/2022 ∙ CTSA Program
Science Update: Youth Suicides Increased in First Year of the Pandemic, NIH-Funded Study Suggests
NICHD ∙ 04/27/2022 ∙ CTSA Program
Viruses in the Gut Influence Inflammatory Bowel Disease
NIH Research Matters ∙ 04/26/2022 ∙ CTSA Program
Making Movement Fun May Help New Moms with Heart Risks
NHLBI ∙ 04/26/2022 ∙ CTSA Program
A More Precise Way to Knock Out Skin Rashes
NIH Director's Blog ∙ 04/26/2022 ∙ NCATS
Presumptive Service Connection for Rare Respiratory Cancers Due to Exposure to Fine Particulate Matter
Federal Register ∙ 04/26/2022 ∙ Rare Diseases
2022 ICTS Symposium Posters
Washington University in St. Louis, Institute of Clinical and Translational Sciences ∙ 04/25/2022 ∙ CTSA Program
If You Build It, Will They Come? Linking ICTS Researcher Engagement and Scientific Productivity
Washington University in St. Louis, Institute of Clinical and Translational Sciences ∙ 04/25/2022 ∙ CTSA Program
Federal Research Funding Has Positive ‘Ripple Effects’
The Ohio State University ∙ 04/22/2022 ∙ NCATS
Early Stage Investigator Spotlight: Siddharth Srivastava Investigates Genetic Causes of Neurodevelopmental Disorders
Rare Diseases Clinical Research Network ∙ 04/21/2022 ∙ RDCRN
Introducing SARS-CoV-2 Variants Overview, NLM’s Latest Tool in the Fight against COVID-19
National Center for Biotechnology Information ∙ 04/20/2022 ∙ Division of Preclinical Innovation
Smartwatches and Fitness Bands Reveal Individual Physiological Responses to COVID-19 Vaccine
The Scripps Research Institute ∙ 04/19/2022 ∙ CTSA Program
Hesperos Shows Potential for In Vitro Approach to Replace Conventional Animal Efficacy Studies for Rare Neuromuscular Disorders
Hesperos, Inc. ∙ 04/19/2022 ∙ SBIR/STIR, Tissue Chip
NCATS Aims to Transform Rare Disease Research
NIH Record ∙ 04/15/2022 ∙ Rare Diseases
Isotonizene Can Be Fun for Anyone
mybjjblog.com ∙ 04/15/2022 ∙ NCATS
Consortium Spotlight: Advancing Discoveries in Neurodevelopmental Disorders
Rare Diseases Clinical Research Network ∙ 04/14/2022 ∙ RDCRN
Three Doses of COVID-19 Vaccine Important for Patients Who Undergo Solid Organ Transplants
Washington University in St. Louis ∙ 04/13/2022 ∙ CTSA Program
New COVID-19 Nasal Spray Outperforms Current Antibody Treatments in Mice
Northwestern University ∙ 04/13/2022 ∙ Tissue Chip
Science Update: Scientists Develop Noninvasive Method to Predict Congenital CMV Infection
NICHD ∙ 04/13/2022 ∙ CTSA Program
The National Economic Burden of Rare Disease Study
EveryLife Foundation for Rare Diseases ∙ 04/12/2022 ∙ Rare Diseases
Five Questions With Lotfi Merabet
Harvard Catalyst ∙ 04/12/2022 ∙ CTSA Program
CHOP Division of Urology Research Highlights 2021-2022
Children’s Hospital of Philadelphia ∙ 04/12/2022 ∙ CTSA Program
Research in Human Kidney Organoids Reveals Target to Prevent Irreversible Kidney Damage
MassaMassachusetts General Hospital ∙ 04/11/2022 ∙ CTSA Program
BARDA Announces Winners of EHR-Focused Pediatric COVID-19 Data Challenge
Federal Laboratory Consortium for Technology Transfer ∙ 04/07/2022 ∙ NCATS
Researchers Identify Oral Bacteria Strains Linked to High Blood Pressure
NHLBI ∙ 04/06/2022 ∙ CTSA Program
Major Grant Renewal to Provide Five More Years of Support for VICTR
Vanderbilt University Medical Center ∙ 04/06/2022 ∙ CTSA Program
A New ‘Moneyball’: Model Switches Up How Baseball Players Are Valued
ScienceBlog.com ∙ 04/06/2022 ∙ CTSA Program
Unlocking Insights from Real-World Data to Help Pediatric COVID-19 Patients
MedicalCountermeasures.gov ∙ 04/06/2022 ∙ CTSA Program
FSU Team Wins Global Competition to Develop Next-Gen Tools, Improve Public Health Solutions
Florida State University ∙ 04/05/2022 ∙ NCATS
New Metric More Accurately Evaluates Physician Performance
Northwestern University ∙ 04/05/2022 ∙ CTSA Program
Convalescent Plasma Could Lower Hospitalization Risk for Newly Infected COVID-19 Patients
The University of Utah ∙ 04/04/2022 ∙ NCATS
New Study Shows Low D3Cr Muscle Mass/Weight Significantly Increases Risk of Hip and Potentially Other Fractures in Older Men
Sutter Health ∙ 04/04/2022 ∙ CTSA Program
ILLInet RECOVER Will Help to Solve the Medical Mystery of “Long COVID”
UIC Center for Clinical and Translational Science ∙ 04/02/2022 ∙ CTSA Program

March 2022

Virpax Pharmaceuticals Reports 2021 Year-End Results
Virpax® Pharmaceuticals, Inc. ∙ 03/31/2022 ∙ NCATS
Patient Spotlight: Billy Anton Balances Management and Lifestyle with Primary Ciliary Dyskinesia
Rare Diseases Clinical Research Network ∙ 03/29/2022 ∙ RDCRN
Santhera and ReveraGen Start Rolling NDA Submission to the FDA for Vamorolone for the Treatment of Duchenne Muscular Dystrophy
Yahoo! Finance ∙ 03/29/2022 ∙ NCATS
'Father of Environmental Justice' and Local High School Students Headline CCTS Conference
University of Kentucky ∙ 03/25/2022 ∙ CTSA Program
Rural Hospital Administrators’ Beliefs on Offering Obstetric Care
University of Minnesota ∙ 03/25/2022 ∙ CTSA Program
Mayo Clinic Researchers Develop New Antibody Test to Diagnose MS
Mayo Clinic ∙ 03/24/2022 ∙ CTSA Program
Biomedical Data Translator Platform Moves to the Next Phase
RENCI (Renaissance Computing Institute) ∙ 03/24/2022 ∙ Biomedical Data Translator
In Animal Study, Implant Churns Out CAR-T Cells to Combat Cancer
North Carolina State University ∙ 03/24/2022 ∙ CTSA Program
COVID-19 Infection Linked to Higher Risk of Neuropathy
Washington University School of Medicine in St. Louis ∙ 03/24/2022 ∙ CTSA Program
Targeting TGF-β for Treatment of Osteogenesis Imperfecta
Baylor College of Medicine ∙ 03/22/2022 ∙ RDCRN
Early Stage Investigator Spotlight: BreAnna Kinghorn Improves Outcomes for Children with Primary Ciliary Dyskinesia
Rare Diseases Clinical Research Network ∙ 03/22/2022 ∙ RDCRN
COVID-19 Makes Living with a Rare Disease Even Harder
National Library of Medicine ∙ 03/22/2022 ∙ RDCRN
Tufts CTSI Publishes First-of-Its-Kind Resource on Real-World Research Conducted with Broadly Engaged, Diverse, and Inclusive Teams
Tufts Clinical and Translational Science Institute ∙ 03/21/2022 ∙ CTSA Program
Help Us Enhance Diversity in Alzheimer’s and Related Dementias Clinical Trials
National Institute on Aging ∙ 03/21/2022 ∙ CTSA Program
"Fine-Tuning" Innovations to Predict Manic Episodes in Bipolar Disorder
UIC Center for Clinical and Translational Science ∙ 03/21/2022 ∙ CTSA Program
Blood Test May Indicate Higher Risk Pregnancies in Patients with COVID-19
Northwestern University ∙ 03/17/2022 ∙ CTSA Program
Relapsing Polychondritis Patients, Advocates, and Researchers Emphasize Awareness, Partnership, and Collaboration with Exhibits on Rare Disease Day 2022 at the National Institutes of Health
Relapsing Polychondritis Foundation ∙ 03/17/2022 ∙ Rare Diseases
Coaching Transforms Researchers and Institutions
University of Minnesota, Clinical & Translational Science Institute ∙ 03/16/2022 ∙ CTSA Program
Finding the ‘Tipping Point’ to Permanent Kidney Damage
NIH Director's Blog ∙ 03/15/2022 ∙ Tissue Chip
Santhera and ReveraGen to Present Efficacy and Safety Data with Vamorolone at 2022 Muscular Dystrophy Association Conference
Santhera Pharmaceuticals and ReveraGen BioPharma ∙ 03/15/2022 ∙ NCATS
Weight Loss Doesn’t Help Pregnancy Chances, UVA’s Collaborative Health Study Finds
University of Virginia ∙ 03/14/2022 ∙ CTSA Program
Seminar Explores Similarities between Long COVID and Traumatic Brain Injury
University at Buffalo, Clinical and Translational Science Institute ∙ 03/14/2022 ∙ CTSA Program
Close the Blinds during Sleep to Protect Your Health
Northwestern University ∙ 03/14/2022 ∙ CTSA Program
Hospitalizations for High Blood Pressure May Be on the Rise
NHLBI ∙ 03/14/2022 ∙ CTSA Program
Consortium Spotlight: Advancing Discoveries in Mucociliary Clearance Diseases
Rare Diseases Clinical Research Network ∙ 03/11/2022 ∙ RDCRN
Prenatal Mindfulness Program Improves Stress Response in Infants
University of California, San Francisco ∙ 03/10/2022 ∙ CTSA Program
Universal Masking in Schools is Shown to Reduce Spread of COVID-19
Duke Clinical Research Institute ∙ 03/09/2022 ∙ CTSA Program
Getting Sufficient Sleep Reduces Calorie Intake
NIH Research Matters ∙ 03/08/2022 ∙ CTSA Program
O-pH, a New UW Dental Tool Prototype, Can Spot the Acidic Conditions That Lead to Cavities
University of Washington ∙ 03/08/2022 ∙ NCATS
Continuing Face Mask Use Could Save U.S. Billions of Dollars
CUNY Graduate School of Public Health and Health Policy ∙ 03/08/2022 ∙ CTSA Program
COVID-19 Immune Response Improves for Months after Vaccination
NIH Research Matters ∙ 03/08/2022 ∙ CTSA Program
Study Shows Structural Racism Can Result in Poorer Leukemia Outcomes
University of Illinois at Chicago ∙ 03/07/2022 ∙ CTSA Program
‘Immune Distraction’ from Previous Colds Leads to Worse COVID Infections
University of Rochester Medical Center ∙ 03/04/2022 ∙ CTSA Program
Pregnant Women Have Lingering Depression Despite Antidepressant Treatment
Northwestern University ∙ 03/04/2022 ∙ CTSA Program
Early Stage Investigator Spotlight: Girish Hiremath Explores the Epidemiology of Eosinophilic Gastrointestinal Diseases
Rare Diseases Clinical Research Network ∙ 03/04/2022 ∙ Rare Diseases, RDCRN
Meet the Makers: NIH Biomedical Engineers Shape Tomorrow’s Technology
The NIH Catalyst ∙ 03/03/2022 ∙ Division of Preclinical Innovation
U of M Researchers Find Cohorting Patient Care Model during Pandemic Improved Patient Outcomes
University of Minnesota Medical School ∙ 03/03/2022 ∙ CTSA Program
Navigating the Rare Disease Odyssey
The Jackson Laboratory ∙ 03/02/2022 ∙ GARD, Rare Diseases
4 Agencies Select 8 Research Projects to Extend Longevity of 3D Tissue Chips to 6 Months
National Aeronautics and Space Administration ∙ 03/01/2022 ∙ Tissue Chip

February 2022

Rare Disease Day 2022: The Evolving Impact of Genomics and Precision Health
Centers for Disease Control and Prevention ∙ 02/28/2022 ∙ GARD, New Therapeutic Uses, Rare Diseases
Exercise Reduces Clotting Risk in Patients with Nonalcoholic Fatty Liver Disease
Penn State ∙ 02/28/2022 ∙ CTSA Program
Alltrna Appoints Rare Disease Clinical Research Expert, Dr. Anne Pariser, as Vice President, Medical and Regulatory Affairs
Yahoo! Finance ∙ 02/28/2022 ∙ Rare Diseases
Trial Innovation Network Provides Resources for Investigators
University at Buffalo ∙ 02/24/2022 ∙ CTSA Program
Community Support Can Make You Healthier — And Can Help You Lose Weight, Too
Mayo Clinic ∙ 02/24/2022 ∙ CTSA Program
Predicting the Chaos in Tourette Syndrome Tics
Washington University in St. Louis ∙ 02/23/2022 ∙ CTSA Program
Rare ≠ Uncommon: Patient Advocates Aim to Increase Visibility of Orphan Diseases
BioCentury, Inc. ∙ 02/22/2022 ∙ Rare Diseases
UVA Health Joins National Trial Testing Medications for Mild to Moderate COVID-19
University of Virginia ∙ 02/21/2022 ∙ CTSA Program
SARS-CoV-2 Infection Increases Risk of Maternal Mortality and Obstetric Complications
Northwestern University, Feinberg School of Medicine ∙ 02/21/2022 ∙ CTSA Program
Steps to Improve Data Gathering on Rare Diseases
Global Genes ∙ 02/18/2022 ∙ Rare Diseases
Children with Insomnia Likely to Continue to Suffer as Adults, Long-Term Study Finds
Penn State ∙ 02/17/2022 ∙ NCATS
Science Federation Highlights Penn State Proposal to Combat Diseases of Despair
Penn State ∙ 02/17/2022 ∙ CTSA Program
Household Food Insecurity during Adolescence is a Risk Factor for Future Disordered Eating and High Weight Status in Young Adulthood
University of Minnesota ∙ 02/17/2022 ∙ CTSA Program
Study Will Test Higher Dose of Ivermectin to Treat Mild-to-Moderate COVID-19
Duke Clinical Research Institute ∙ 02/17/2022 ∙ CTSA Program
Virtual Coaching to Increase Physical Activity in Frail Older Adults
University of Illinois Chicago, Center for Clinical and Translational Science ∙ 02/17/2022 ∙ CTSA Program
Quantifying the Economic Burden of Rare Diseases on Families and Health Care Systems
WCG Institute ∙ 02/17/2022 ∙ Rare Diseases
How Broad Scientists Are Bridging the Gap between Biological Insights and New Therapies
Broad Institute ∙ 02/16/2022 ∙ NCATS
Sparking Change: UK Undergrad Program for Health Equity Research Expands to KSU
University of Kentucky Center for Clinical and Translational Science ∙ 02/15/2022 ∙ CTSA Program
Targeting TGF-β for Treatment of Osteogenesis Imperfecta
Baylor College of Medicine ∙ 02/15/2022 ∙ RDCRN
Antibodies Improve in Quality for Months after COVID-19 Vaccination
Washington University in St. Louis ∙ 02/15/2022 ∙ CTSA Program
IRP Pushes Forward in Fight against Pandemic Virus
I Am Intramural Blog ∙ 02/14/2022 ∙ Division of Preclinical Innovation
Hillstream BioPharma Provides Business Review with Key Pipeline Updates
Hillstream Biopharma, Inc. ∙ 02/14/2022 ∙ NCATS
Renewal of License Subscription to Access Flare LigandPro, Forge GUI, Spark GUI and Engine Broker 5-User Group Software
Global Database, Ltd. ∙ 02/11/2022 ∙ Division of Preclinical Innovation
Improving Models to Predict Cardiovascular Disease in Individuals with Kidney Dysfunction
American Society of Nephrology ∙ 02/10/2022 ∙ NCATS
Virpax Reports Favorable Preclinical Safety Data for Envelta™ for the Treatment of Acute and Chronic Pain
Virpax® Pharmaceuticals, Inc. ∙ 02/10/2022 ∙ NCATS
Narratives of Discovery – Article 5: George Hripcsak
Columbia University, Irving Institute for Clinical and Translational Research ∙ 02/10/2022 ∙ CTSA Program
Improving Models to Predict Cardiovascular Disease in Individuals with Kidney Dysfunction
American Society of Nephrology ∙ 02/10/2022 ∙ NCATS
Results of First Clinical Trial of Niclosamide Antiviral in Patients with Covid-19 Show Further Research Needed
Tufts Clinical and Translational Science Institute ∙ 02/09/2022 ∙ CTSA Program
K Scholar’s Research on Mental Health and Pediatric Diabetes Highlighted by Cleveland Clinic
University of Kentucky Center for Clinical and Translational Science ∙ 02/08/2022 ∙ CTSA Program
Innovation to Respond to COVID-19
U.S. Food and Drug Administration ∙ 02/08/2022 ∙ Division of Preclinical Innovation
COVID-19 Linked to Serious Health Complications during Pregnancy
University of Utah Health ∙ 02/07/2022 ∙ CTSA Program
New Antiviral Drug Combination Is Highly Effective against SARS-CoV-2, Penn Study Finds
Penn Medicine ∙ 02/07/2022 ∙ Division of Preclinical Innovation
Nationwide Study of 'Long COVID' to Launch at University of Colorado Anschutz Medical Campus
Colorado Clinical and Translational Sciences Institute ∙ 02/07/2022 ∙ CTSA Program
A Guide to Next Steps after Not Receiving a Diagnosis
Global Genes ∙ 02/04/2022 ∙ GARD
Nancy Schoenberg: Listening to Communities to Create Equitable Solutions
University of Kentucky Center for Clinical and Translational Science ∙ 02/01/2022 ∙ CTSA Program
Survey Finds Support for Cancer Warnings on Alcohol
WorldHealth.net ∙ 02/01/2022 ∙ CTSA Program
Hillstream BioPharma Announces Acceptance of Abstract at AACR 2022 Annual Meeting Highlighting HSB-510, a Novel Quatramer-based, First-in-Class Dual Inhibitor of HDAC6 and PI3K-delta Downregulating c-myc Expression
Hillstream Biopharma, Inc. ∙ 02/01/2022 ∙ NCATS

January 2022

What You Need to Know about the MTHFR Gene Mutation
Ketogenic.com ∙ 01/31/2022 ∙ GARD
Why Scientists Are Racing to Develop More COVID Antivirals
Cornell University, College of Veterinary Medicine ∙ 01/27/2022 ∙ Division of Preclinical Innovation
Uncontrolled Blood Pressure Is Sending More People to the Hospital
Cedars-Sinai ∙ 01/27/2022 ∙ CTSA Program
Study Examines Pandemic Impact on Suicide Attempt Survivors
University of Kentucky Center for Clinical and Translational Science ∙ 01/27/2022 ∙ CTSA Program
NIH Seeks Input on Rural Telehealth Research Needs
American Academy of Family Physicians ∙ 01/27/2022 ∙ NCATS
BU Researchers Identify a New Protein That Enables SARS-CoV-2 Access into Cells
Boston University School of Medicine ∙ 01/26/2022 ∙ CTSA Program
Culturally-Centered Care Increases Feelings of Respect, Autonomy for Birthing People of Color
University of Minnesota ∙ 01/25/2022 ∙ CTSA Program
NCI Support for Basic Science Paves Way for Kidney Cancer Drug Belzutifan
NIH Director's Blog ∙ 01/25/2022 ∙ GARD
SpaceX CRS-24 Splashes Down Safely after One Month on the ISS, Returns Science to Researchers on Earth
ISS National Laboratory ∙ 01/25/2022 ∙ Tissue Chip
New Study Validates Benefits of Convalescent Plasma for Some Patients with COVID-19
NYU Langone Health ∙ 01/25/2022 ∙ CTSA Program
Men Prone to Anxiety, Worry May Develop More Risk Factors for Heart Disease, Stroke and Diabetes
American Heart Association, Inc. ∙ 01/24/2022 ∙ CTSA Program
Why Scientists Are Racing to Develop More COVID Antivirals
Head Topics ∙ 01/24/2022 ∙ Division of Preclinical Innovation
Essentia Health Joins Nationwide Study to Test Medications for COVID-19
Essentia Health ∙ 01/24/2022 ∙ CTSA Program
Scientists Find Predictors of Heart Disease among Black Americans That Are Shared across Ethnicities
Beth Israel Deaconess Medical Center ∙ 01/21/2022 ∙ CTSA Program
123rd ACD Session Focuses on Maintaining Momentum
NIH Record ∙ 01/21/2022 ∙ Bespoke Gene Therapy Consortium
NIH Funds CUNY SPH and West Point AI Center for Precision Nutrition and Health
CUNY Graduate School of Public Health & Health Policy ∙ 01/20/2022 ∙ All of Us Research Program
NIH Awards $170 Million for Precision Nutrition Study
NIH Common Fund ∙ 01/20/2022 ∙ All of Us Research Program
Should Alcohol Have Warning Labels about Cancer Risk? Most Americans Say ‘Yes’
University of Virginia ∙ 01/20/2022 ∙ CTSA Program
Early Stage Investigator Spotlight: Danielle Arnold Explores Transplant Strategies for Primary Immune Deficiencies
Rare Diseases Clinical Research Network ∙ 01/19/2022 ∙ RDCRN
Race-Based Prescribing for Black People with High Blood Pressure Shows No Benefit
University of California, San Francisco ∙ 01/18/2022 ∙ CTSA Program
Weight Loss before Fertility Treatment May Not Increase Births for Obese Women
Penn State ∙ 01/18/2022 ∙ CTSA Program
Survival Rate Increases for Extremely Preterm Infants in NIH-Funded Research Network
NICHD ∙ 01/18/2022 ∙ NCATS
College of Health Faculty Awarded Federal, State Grants to Address Health Concerns
Lehigh University ∙ 01/18/2022 ∙ NCATS
Self-Compassion May Support a Healthy Heart
NHLBI ∙ 01/18/2022 ∙ CTSA Program
New Paper Proposes Diversity, Equity and Inclusion Measures to Combat Structural Health Inequities
UC Davis Health ∙ 01/15/2022 ∙ CTSA Program
Pilot RCT of Angiotensin II vs. Vasopressin in Septic Shock
ClinicalTrials.gov ∙ 01/14/2022 ∙ NCATS
E-Cigarette Users Who Test Positive for COVID-19 Are More Likely to Experience COVID-19 Symptoms
Mayo Clinic ∙ 01/13/2022 ∙ CTSA Program
UCLA-Led Team Refines 'Kick and Kill' Strategy Aimed at Eliminating HIV-Infected Cells
University of California, Los Angeles ∙ 01/11/2022 ∙ CTSA Program
Clear Creek Bio Advances Its Highly Potent SARS-CoV-2 PLpro Inhibitors in Discovery of an Oral Direct-Acting Antiviral to Treat COVID-19
Clear Creek Bio, Inc. ∙ 01/06/2022 ∙ NCATS
Winners of Biomedical Innovation Program Awards Address Significant Clinical Problems
Oregon Health & Science University ∙ 01/04/2022 ∙ CTSA Program
Alumnus and Engineer Collaborate on 3D Printing to Advance Microfluidic Systems
Virginia Polytechnic Institute and State University ∙ 01/03/2022 ∙ SBIR/STIR
Making Hard Choices: A Bioethicist on Crisis Standards of Care
DailyNurse.com ∙ 01/03/2022 ∙ NCATS

December 2021

Ovarian Cancer Researchers Bring Natural Product β-escin to the Fore
University of Chicago Medicine ∙ 12/27/2021 ∙ Division of Preclinical Innovation
What Makes an mRNA Vaccine so Effective Against Severe COVID-19?
Washington University School of Medicine in St. Louis ∙ 12/23/2021 ∙ CTSA Program
A Living Pain Circuit
Tulane University, AxoSim, Inc. ∙ 12/21/2021 ∙ HEAL
Health Disparities Emerge in Blood Pressure Control
NHLBI ∙ 12/21/2021 ∙ CTSA Program
Early Use of Convalescent Plasma May Help Outpatients with COVID-19 Avoid Hospitalization
Johns Hopkins Medicine ∙ 12/21/2021 ∙ CTSA Program
Emulate Brain-Chip to Study the Effects of Microgravity on Human Brain Physiology at the International Space Station
Emulate ∙ 12/21/2021 ∙ Tissue Chip
What Is Engaged Scholarship and How Can It Improve Your Research?
Inside Higher Ed ∙ 12/20/2021 ∙ CTSA Program
Gene Therapy Consortium Provides New Hope for Rare Disease Suffers
North Carolina Biotechnology Center ∙ 12/16/2021 ∙ Bespoke Gene Therapy Consortium
Patient Spotlight: Mitchell Magyar Makes an Impact on Urea Cycle Disorder Research
Rare Diseases Clinical Research Network ∙ 12/16/2021 ∙ RDCRN
UF Leads Team Ready to Tackle Vaccine Skepticism in Florida and Beyond
University of Florida Health ∙ 12/16/2021 ∙ CTSA Program
Digital Therapy for Prenatal Insomnia May Prevent Postpartum Depression
University of California, San Francisco ∙ 12/15/2021 ∙ CTSA Program
Digital Therapy for Prenatal Insomnia May Prevent Postpartum Depression
University of California, San Francisco, Weill Institute for Neurosciences ∙ 12/15/2021 ∙ CTSA Program
SpaceX CRS-24 Launching Multiple Life Science Investigations to the International Space Station
ISS National Laboratory ∙ 12/15/2021 ∙ Tissue Chip
Daytime Meals May Reduce Health Risks of Night Shift Work
NIH Research Matters ∙ 12/14/2021 ∙ CTSA Program
Editorial: Sporadic Early-Onset Colorectal Cancer—Appreciating Aetiologic Complexity
Alimentary Pharmacology & Therapeutics ∙ 12/14/2021 ∙ CTSA Program
Australian GenesisCare Doctors Co-Author World-First International Consensus Statement on Cardio-Oncology
GenesisCare ∙ 12/13/2021 ∙ CTSA Program
SpaceX CRS-24 Mission Overview
ISS National Laboratory ∙ 12/13/2021 ∙ Tissue Chip
Early Investigator Spotlight: UCDC Trainees Drive Discoveries in Urea Cycle Disorders
Rare Diseases Clinical Research Network ∙ 12/09/2021 ∙ RDCRN
E-Cigs with Cigarette-like Nicotine Delivery May Help Smokers Quit
Penn State ∙ 12/08/2021 ∙ CTSA Program
Youth with Autism Spectrum Disorder Should be Screened for Abnormal Cholesterol Levels, Physicians Recommend
Kennedy Krieger Institute ∙ 12/07/2021 ∙ CTSA Program
Antipsychotic Drugs May Increase Risk of Breast Cancer
Washington University School of Medicine in St. Louis ∙ 12/06/2021 ∙ CTSA Program
Consortium Spotlight: Advancing Discoveries in Urea Cycle Disorders
Rare Diseases Clinical Research Network ∙ 12/03/2021 ∙ RDCRN
Rescuing Drug Castoffs
HSP Research Foundation ∙ 12/01/2021 ∙ New Therapeutic Uses
Who Develops Mild Cognitive Impairment? What Predicts Who Then Develops Dementia?
American Academy of Neurology ∙ 12/01/2021 ∙ CTSA Program
Platforms of Hope: Realizing the Potential of Genetic Medicines
Global Genes ∙ 12/01/2021 ∙ Bespoke Gene Therapy Consortium, Rare Diseases

November 2021

Encouraging News on Gene Therapy for Hemophilia A
NIH Director's Blog ∙ 11/30/2021 ∙ GARD
Franciscan Health Michigan City Joins Nationwide Study to Test COVID-19 Medication Efficacy
Franciscan Health Michigan City ∙ 11/30/2021 ∙ CTSA Program
Smartwatch Data Used to Predict Clinical Test Results
NIBIB ∙ 11/30/2021 ∙ CTSA Program
Research Supports Multidisciplinary Approach for Pediatric Diabetes Management
University of Kentucky ∙ 11/30/2021 ∙ CTSA Program
Recognizing This Season of Giving
Kansas Common Sense ∙ 11/29/2021 ∙ CTSA Program
COVID-19: Ciclesonide Failed to Accelerate Recovery in Mild Disease
Physician's Weekly ∙ 11/26/2021 ∙ CTSA Program
Pinpointing Cancer Therapy Targets
Cedars Sinai ∙ 11/24/2021 ∙ CTSA Program
Santhera and ReveraGen Announce Positive Topline Results with Vamorolone after Completion of the VISION-DMD Study
Santhera Pharmaceuticals and ReveraGen BioPharma, Inc. ∙ 11/23/2021 ∙ NCATS
Senators Moran and Blunt Welcome NIH’s Dr. Rutter to KU Medical Center to Visit the Clinical and Translational Science Institute, Frontiers
University of Kansas Medical Center ∙ 11/22/2021 ∙ CTSA Program
Boosters Increase Protection over Full Vaccine Dose
Northwestern University ∙ 11/22/2021 ∙ CTSA Program
Hesperos Validates Utility of Human-on-a-Chip® Approach to Model Rare Autoimmune Disease, Myasthenia Gravis
Hesperos, Inc. ∙ 11/22/2021 ∙ Tissue Chip
Researchers Use Model of Hypothalamus to Implicate Genes Associated with Sleep, BMI, Puberty, and More
Children’s Hospital of Philadelphia ∙ 11/19/2021 ∙ CTSA Program
iTHRIV Funds Efforts to Combat Obesity, Understand Self-Harm, and Reduce Waste by Virginia Tech Scientists and Partners
Virginia Polytechnic Institute and State University ∙ 11/19/2021 ∙ CTSA Program
Winners Announced for 2021 Innovation Challenge
Loyola University Chicago, Parkinson School of Health Sciences and Public Health ∙ 11/18/2021 ∙ SBIR/STIR
New Analyses of Two AZD7442 COVID-19 Phase III Trials in High-Risk Populations Confirm Robust Efficacy and Long-Term Prevention
AstraZeneca ∙ 11/18/2021 ∙ CTSA Program
Fatal Heart Attack or Stroke Could Be First Sign of CVD in Some Smokers
American Heart Association, Inc. ∙ 11/17/2021 ∙ CTSA Program
Smokers More Likely to Die from Heart Disease than Lung Cancer
ClinicalNews.org - AlchePharma ∙ 11/17/2021 ∙ CTSA Program
Patient Spotlight: Fynan Family Fueled by OI Research
Rare Diseases Clinical Research Network ∙ 11/16/2021 ∙ RDCRN
The Search for the ‘Unknown Known’
The University of Alabama at Birmingham ∙ 11/16/2021 ∙ Biomedical Data Translator
iTHRIV Backs Bids to Improve Lung Transplant Outcomes, Reduce Waste
University of Virginia ∙ 11/16/2021 ∙ CTSA Program
How to Solve the Tragedy of the Commons Caused by Reliance on the Patent System to Develop New Drugs
Crowd Funded Cures ∙ 11/16/2021 ∙ NCATS
NIH Applicant Assistance Program (AAP) Now Open – 11/15/21
Innovation Partnership ∙ 11/15/2021 ∙ SBIR/STIR
VUMC Tests Drugs for COVID Outpatient Treatment
Vanderbilt University Medical Center ∙ 11/11/2021 ∙ CTSA Program
Compound Developed at UArizona Health Sciences Provides Innovative Pain Relief
The University of Arizona Health Sciences ∙ 11/10/2021 ∙ Division of Preclinical Innovation
Virpax Advances Envelta™ Development with NCATS Under CRADA Agreement
Virpax® Pharmaceuticals, Inc. ∙ 11/10/2021 ∙ NCATS
Retrospective Study Finds That Cancer Drug Also Lowers Blood Glucose
Mayo Clinic ∙ 11/09/2021 ∙ CTSA Program
University Launches Effort to ‘Revolutionize the Undergraduate Experience’
University of Miami ∙ 11/09/2021 ∙ SBIR/STIR
Mindfulness Linked to Better Psychological Health a Year or Longer after Cardiac Arrest
American Heart Association, Inc. ∙ 11/08/2021 ∙ NCATS
Programing the Body to Make Its Own Medicine with Gene Therapy
Global Genes ∙ 11/05/2021 ∙ Bespoke Gene Therapy Consortium
School-Based Screening Increases Identification of, Treatment for Depression
Penn State College of Medicine ∙ 11/05/2021 ∙ CTSA Program
UT Southwestern designated founding Rare Disease Center of Excellence
The University of Texas Southwestern Medical Center ∙ 11/04/2021 ∙ Rare Diseases
Memories… Or Why Inflammatory Arthritis Always Recurs in Certain Joints
Mirage News ∙ 11/04/2021 ∙ CTSA Program